Résultats de recherche
Il y a 14 heures · EOS (EOS) is a blockchain platform launched by Block.one in June 2018, designed to support decentralized applications (dApps) and smart contracts with high scalability and low latency. It operates on a delegated proof-of-stake (DPoS) consensus mechanism, which enhances transaction speeds and reduces energy consumption. The EOSIO software allows for the flexibility and ease of developing ...
Il y a 14 heures · Nouvelles du 8 juillet, le réseau EOS a annoncé le lancement d'un programme de récompenses de staking de 250 millions d'EOS dans le cadre de son plan d'amél | Actualités Bitget
Il y a 14 heures · Cryptocurrency Industry News. · Jul 08, 2024, 14:35 BST. Today July 8 EOS Network launches a 250M EOS staking rewards program as part of the network’s revamped tokenomics plan. Under the new staking rewards schedule, 85.6K EOS is distributed daily to Stakers. The revamped EOS staking program rewards early stakers for participating, with an ...
Il y a 14 heures · Credit: Marcelo Cohen. Hurricanes may be limiting the height of mangroves along the U.S. Gulf Coast. This knowledge could affect the ways that land managers plan for storm mitigation measures ...
Il y a 14 heures · I'm seeing BLUE! What can I do? - posted in Experienced Deep Sky Imaging: Hello to everyone!! I just bought a new filter for astrophotography the Astronomik CLS clip in filter for canon EOS(crop sensor).It was a moonless night(new moon) and I was under bortle 5 skies. So I gave it a shoot and I photographed the lagoon nebula for just an hour and a half,because I did not have time. Then I ...
Il y a 14 heures · About Belrestotug (EOS-448/ GSK4428859A) Belrestotug is an Fc active human immunoglobulin G1, or IgG1, monoclonal antibody (mAb) targeting T cell immunoglobulin and immunoreceptor tyrosine-based ...
Il y a 14 heures · About Belrestotug (EOS-448/ GSK4428859A) Belrestotug is an Fc active human immunoglobulin G1, or IgG1, monoclonal antibody (mAb) targeting T cell immunoglobulin and immunoreceptor tyrosine-based inhibitory motif domains (TIGIT), an important inhibitory receptor which contributes to the suppression of innate immune responses against cancer.
